CA2470111A1 - Production of chirally pure .alpha.-amino acids and n-sulfonyl .alpha.-amino acids - Google Patents

Production of chirally pure .alpha.-amino acids and n-sulfonyl .alpha.-amino acids Download PDF

Info

Publication number
CA2470111A1
CA2470111A1 CA002470111A CA2470111A CA2470111A1 CA 2470111 A1 CA2470111 A1 CA 2470111A1 CA 002470111 A CA002470111 A CA 002470111A CA 2470111 A CA2470111 A CA 2470111A CA 2470111 A1 CA2470111 A1 CA 2470111A1
Authority
CA
Canada
Prior art keywords
substituted
sulfonyl
alpha
amino acid
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002470111A
Other languages
English (en)
French (fr)
Inventor
Lynn Resnick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46204648&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2470111(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US10/014,304 external-priority patent/US6610734B2/en
Priority claimed from US10/166,896 external-priority patent/US6657070B2/en
Application filed by Individual filed Critical Individual
Publication of CA2470111A1 publication Critical patent/CA2470111A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002470111A 2001-12-11 2002-11-26 Production of chirally pure .alpha.-amino acids and n-sulfonyl .alpha.-amino acids Abandoned CA2470111A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/014,304 2001-12-11
US10/014,304 US6610734B2 (en) 2000-12-13 2001-12-11 Heterocyclic sulfonamide inhibitors of beta amyloid production
US10/166,896 US6657070B2 (en) 2000-12-13 2002-06-11 Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
US10/166,896 2002-06-11
PCT/US2002/038117 WO2003050062A2 (en) 2001-12-11 2002-11-26 PRODUCTION OF CHIRALLY PURE α-AMINO ACIDS ADN N-SULFONYL α-AMINO ACIDS

Publications (1)

Publication Number Publication Date
CA2470111A1 true CA2470111A1 (en) 2003-06-19

Family

ID=46204648

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002470111A Abandoned CA2470111A1 (en) 2001-12-11 2002-11-26 Production of chirally pure .alpha.-amino acids and n-sulfonyl .alpha.-amino acids

Country Status (7)

Country Link
EP (1) EP1461332A4 (ja)
JP (1) JP4615861B2 (ja)
AU (2) AU2002351170B8 (ja)
CA (1) CA2470111A1 (ja)
MX (1) MXPA04005366A (ja)
TW (1) TWI260316B (ja)
WO (1) WO2003050062A2 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2436526C (en) 2000-12-13 2010-10-19 Wyeth Heterocyclic sulfonamide inhibitors of beta amyloid production
NZ542468A (en) 2003-03-31 2009-01-31 Wyeth Corp Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
CN1910158A (zh) 2004-01-16 2007-02-07 惠氏公司 含有氮杂环的β淀粉样蛋白生成的杂环磺酰胺抑制剂
JP2009534385A (ja) 2006-04-21 2009-09-24 ワイス キラル的に純粋なアミノアルコール中間体、それらの誘導体の製造、及びそれらの使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3802981A1 (de) * 1988-02-02 1989-08-10 Basf Ag Verfahren zur reduktion reduzierbarer verbindungen
US5264577A (en) * 1992-04-22 1993-11-23 Warner-Lambert Company Cyclic amino acids and derivatives thereof
US5968942A (en) * 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
KR100336699B1 (ko) * 1992-08-25 2002-05-13 윌리암스 로저 에이 레트로바이러스 프로테아제 저해제로서 유용한히드록시에틸아미노 술폰아미드
US6191306B1 (en) * 1999-08-03 2001-02-20 Eastman Chemical Company Process for the preparation of cyclopropylglycine

Also Published As

Publication number Publication date
AU2009251195A1 (en) 2010-01-21
JP4615861B2 (ja) 2011-01-19
EP1461332A4 (en) 2009-10-21
AU2002351170B2 (en) 2009-09-24
WO2003050062A3 (en) 2003-11-20
EP1461332A2 (en) 2004-09-29
AU2002351170A1 (en) 2003-06-23
WO2003050062A2 (en) 2003-06-19
MXPA04005366A (es) 2004-09-27
TW200306292A (en) 2003-11-16
AU2002351170B8 (en) 2009-10-08
TWI260316B (en) 2006-08-21
JP2005511727A (ja) 2005-04-28

Similar Documents

Publication Publication Date Title
US6610734B2 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
US7858658B2 (en) Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
AU2002245123A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
US6657070B2 (en) Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
BRPI0707741A2 (pt) mÉtodos para preparar um amino Álcool, ou sal do mesmo, e um Álcool substituÍdo por sulfonamida
US7598422B2 (en) Production of chirally pure amino alcohol intermediates, derivatives thereof, and uses thereof
AU2009251195A1 (en) Production of chirally pure alpha-amino acids and n-sulfonyl alpha-amino acids
HU201047B (en) Process for production of derivatives of tienil-ethil-amin
AU2002359519B2 (en) Process for the synthesis of chirally pure beta-amino-alcohols
US20180230122A1 (en) Production method for heteroarylcarboxylic acid ester derivative, production intermediate thereof, and crystal
JP5410677B2 (ja) 光学活性アミノペンタン誘導体の製造方法、および中間体とその製造方法
HU227730B1 (en) Process for the preparation of duloxetine and for their the intermediates
MXPA97003899A (en) Arilacrilam derivative

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead